EULAR 2023 | Welcome message from the EULAR President
Since its foundation in 1947, the European Alliance of Associations for Rheumatology, EULAR, has been recognised in the wide-ranging spectrum of World Rheumatology as a prestigious and reputable non-profit organisation with the highest profile on the continent. Among the multitude of outstanding EULAR activities, the EULAR European Congress of Rheumatology represents the flagship of our organisation, every year providing the utmost rheumatology congress experience.
The EULAR Congress is comprised of an extensive network of innovative minds working towards illustrating the latest scientific breakthroughs in clinical, translational, and basic sciences, discussing what is new in dedicated sessions, presenting data on how to treat rheumatic and musculoskeletal diseases (RMDs), giving view to the transfer of results from bench to bedside, showing the practical aspects of our specialty in specific workshop discussions, offering debates, and, in essence, displaying the future of Rheumatology.
2022 was an extraordinary year for EULAR, as we held our first-ever hybrid Congress in Copenhagen and marked our 75th anniversary! Thanks to the great flexibility of the EULAR Rheumatology Community and its high capacity to rapidly adapt to the ever-evolving challenges faced in the pandemic era, EULAR prevailed with this new and highly innovative congress structure, attracting a total of more than 14,000 participants onsite and virtually.
EULAR recognises the pivotal role face-to-face interactions play for our doctors, delegates, and patients, and we appreciate the importance, value, and benefits of an onsite congress experience. Therefore, we are excited to announce that in 2023 we are shifting to our original onsite-only congress experience, with on-demand access available after the live congress days.
The EULAR 2023 Congress will take place in one of the most beautiful and vibrant cities in Europe – Milan! We look forward to returning to a city that acknowledges our organisation and supports its three pillars and communities, aiming to reduce the impact of RMDs on those afflicted and improve their social position and quality of life. We look forward to sharing our new strategy for 2024 - 2028, recent developments in Rheumatology, scientific sessions, abstracts, and more.
I am extremely proud of EULAR’s achievements thus far, and I would like to thank all members of the EULAR Family, the EULAR Office, and the faculty of the EULAR 2023 Congress for their commitment to this new experience. And my special thanks to the numerous delegates who will attend our marvellous congress in 2023.
I am looking forward to meeting you all onsite, in Milan, on 31 May – 03 June, 2023.
My warmest regards,